PHAXIAM Therapeutics SA (DELISTED) (PHXM:DL)
3.10
0.00 (0.00%)
USD |
NASDAQ |
Mar 11, 16:00
PHAXIAM Therapeutics Total Assets (Quarterly)
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | 71.22M |
| December 31, 2022 | 49.13M |
| June 30, 2022 | 68.93M |
| December 31, 2021 | 75.60M |
| June 30, 2021 | 99.73M |
| December 31, 2020 | 98.89M |
| June 30, 2020 | 100.22M |
| December 31, 2019 | 132.79M |
| September 30, 2019 | 149.57M |
| June 30, 2019 | 165.50M |
| December 31, 2018 | 191.99M |
| June 30, 2018 | 210.61M |
| December 31, 2017 | 234.25M |
| June 30, 2017 | 113.60M |
| Date | Value |
|---|---|
| June 30, 2017 | 113.60M |
| December 31, 2016 | 47.54M |
| June 30, 2016 | 49.36M |
| June 30, 2016 | 49.36M |
| December 31, 2015 | 57.95M |
| June 30, 2015 | 40.49M |
| June 30, 2015 | 40.49M |
| December 31, 2014 | 49.38M |
| June 30, 2014 | 20.34M |
| June 30, 2014 | 20.34M |
| December 31, 2013 | 24.79M |
| June 30, 2013 | 29.17M |
| June 30, 2013 | 29.17M |
| December 31, 2012 | 13.42M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
49.13M
Minimum
Dec 2022
165.50M
Maximum
Jun 2019
101.16M
Average
99.31M
Median
Total Assets (Quarterly) Benchmarks
| DBV Technologies SA | 145.90M |
| Cellectis SA | 334.27M |
| Genfit SA | 192.20M |
| Innate Pharma SA | 203.61M |
| Inventiva SA | 76.89M |